narciclasine has been researched along with Carcinoma, Anaplastic in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Darro, F; Dumont, P; Ingrassia, L; Kiss, R; Lefranc, F; Ribaucour, F; Roland, I; Rouzeau, S; Thomas, S | 1 |
1 other study(ies) available for narciclasine and Carcinoma, Anaplastic
Article | Year |
---|---|
The Amaryllidaceae isocarbostyril narciclasine induces apoptosis by activation of the death receptor and/or mitochondrial pathways in cancer cells but not in normal fibroblasts.
Topics: Amaryllidaceae Alkaloids; Antineoplastic Agents, Phytogenic; Apoptosis; BH3 Interacting Domain Death Agonist Protein; Breast Neoplasms; Carcinoma; Caspases; Cytochromes c; DNA Fragmentation; Drug Resistance, Neoplasm; Enzyme Activation; fas Receptor; Female; Fibroblasts; Humans; Male; Mitochondria; Narcissus; Neoplasm Proteins; Phenanthridines; Prostatic Neoplasms; Receptors, TNF-Related Apoptosis-Inducing Ligand; Receptors, Tumor Necrosis Factor | 2007 |